Clinical impact of circulating tumor RAS and BRAF mutation dynamics in metastatic colorectal cancer patients treated with first-line chemotherapy plus anti-EGFR therapy: Combined analysis of two prospective clinical trials

C. Montagut; V. Alonso; P. Escudero; C. Fernández-Martos; A. Salud Salvia; M. Méndez; J. Gallego Plazas; J. R. Rodriguez; M. Martín-Richard; J. Fernández-Plana; J. Aparicio; J. Feliu Batlle; X. García de Albéniz; F. Rojo; V. Fernández; B. Claes; G. G. Maertens; E. Sablon; B. A. W. Jacobs; J. Maurel

doi:10.1093/annonc/mdy281.091

Clinical impact of circulating tumor RAS and BRAF mutation dynamics in metastatic colorectal cancer patients treated with first-line chemotherapy plus anti-EGFR therapy: Combined analysis of two prospective clinical trials

C. Montagut
, V. Alonso
, P. Escudero
, C. Fernández-Martos
, A. Salud Salvia
, M. Méndez
, J. Gallego Plazas
, J. R. Rodriguez
, M. Martín-Richard
, J. Fernández-Plana
, J. Aparicio
, J. Feliu Batlle
, X. García de Albéniz
, F. Rojo
, V. Fernández
, B. Claes
, G. G. Maertens
, E. Sablon
, B. A. W. Jacobs
, J. Maurel

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	viii182
Journal	Annals of oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy281.091
Publication status	Published - 1 Oct 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1093/annonc/mdy281.091

Cite this

Montagut, C., Alonso, V., Escudero, P., Fernández-Martos, C., Salud Salvia, A., Méndez, M., Gallego Plazas, J., Rodriguez, J. R., Martín-Richard, M., Fernández-Plana, J., Aparicio, J., Feliu Batlle, J., García de Albéniz, X., Rojo, F., Fernández, V., Claes, B., Maertens, G. G., Sablon, E., Jacobs, B. A. W., & Maurel, J. (2018). Clinical impact of circulating tumor RAS and BRAF mutation dynamics in metastatic colorectal cancer patients treated with first-line chemotherapy plus anti-EGFR therapy: Combined analysis of two prospective clinical trials. Annals of oncology, 29, viii182. https://doi.org/10.1093/annonc/mdy281.091

@article{a9b97c5a1a0f498798c5dc8e8abe1340,

title = "Clinical impact of circulating tumor RAS and BRAF mutation dynamics in metastatic colorectal cancer patients treated with first-line chemotherapy plus anti-EGFR therapy: Combined analysis of two prospective clinical trials",

author = "C. Montagut and V. Alonso and P. Escudero and C. Fern{\'a}ndez-Martos and \{Salud Salvia\}, A. and M. M{\'e}ndez and \{Gallego Plazas\}, J. and Rodriguez, \{J. R.\} and M. Mart{\'i}n-Richard and J. Fern{\'a}ndez-Plana and J. Aparicio and \{Feliu Batlle\}, J. and \{Garc{\'i}a de Alb{\'e}niz\}, X. and F. Rojo and V. Fern{\'a}ndez and B. Claes and Maertens, \{G. G.\} and E. Sablon and Jacobs, \{B. A. W.\} and J. Maurel",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy281.091",

language = "English",

volume = "29",

pages = "viii182",

journal = "Annals of oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Montagut, C, Alonso, V, Escudero, P, Fernández-Martos, C, Salud Salvia, A, Méndez, M, Gallego Plazas, J, Rodriguez, JR, Martín-Richard, M, Fernández-Plana, J, Aparicio, J, Feliu Batlle, J, García de Albéniz, X, Rojo, F, Fernández, V, Claes, B, Maertens, GG, Sablon, E, Jacobs, BAW & Maurel, J 2018, 'Clinical impact of circulating tumor RAS and BRAF mutation dynamics in metastatic colorectal cancer patients treated with first-line chemotherapy plus anti-EGFR therapy: Combined analysis of two prospective clinical trials', Annals of oncology, vol. 29, pp. viii182. https://doi.org/10.1093/annonc/mdy281.091

Clinical impact of circulating tumor RAS and BRAF mutation dynamics in metastatic colorectal cancer patients treated with first-line chemotherapy plus anti-EGFR therapy: Combined analysis of two prospective clinical trials. / Montagut, C.; Alonso, V.; Escudero, P. et al.
In: Annals of oncology, Vol. 29, 01.10.2018, p. viii182.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Clinical impact of circulating tumor RAS and BRAF mutation dynamics in metastatic colorectal cancer patients treated with first-line chemotherapy plus anti-EGFR therapy: Combined analysis of two prospective clinical trials

AU - Montagut, C.

AU - Alonso, V.

AU - Escudero, P.

AU - Fernández-Martos, C.

AU - Salud Salvia, A.

AU - Méndez, M.

AU - Gallego Plazas, J.

AU - Rodriguez, J. R.

AU - Martín-Richard, M.

AU - Fernández-Plana, J.

AU - Aparicio, J.

AU - Feliu Batlle, J.

AU - García de Albéniz, X.

AU - Rojo, F.

AU - Fernández, V.

AU - Claes, B.

AU - Maertens, G. G.

AU - Sablon, E.

AU - Jacobs, B. A. W.

AU - Maurel, J.

PY - 2018/10/1

Y1 - 2018/10/1

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85081527646&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/32136347

U2 - 10.1093/annonc/mdy281.091

DO - 10.1093/annonc/mdy281.091

M3 - Article

C2 - 32136347

SN - 0923-7534

VL - 29

SP - viii182

JO - Annals of oncology

JF - Annals of oncology

ER -

Montagut C, Alonso V, Escudero P, Fernández-Martos C, Salud Salvia A, Méndez M et al. Clinical impact of circulating tumor RAS and BRAF mutation dynamics in metastatic colorectal cancer patients treated with first-line chemotherapy plus anti-EGFR therapy: Combined analysis of two prospective clinical trials. Annals of oncology. 2018 Oct 1;29:viii182. doi: 10.1093/annonc/mdy281.091

Clinical impact of circulating tumor RAS and BRAF mutation dynamics in metastatic colorectal cancer patients treated with first-line chemotherapy plus anti-EGFR therapy: Combined analysis of two prospective clinical trials

UN SDGs

Access to Document

Other files and links

Cite this